Electrophysiological effects of irbesartan in patients with paroxysmal atrial fibrillation (AF)
Phase of Trial: Phase III
Latest Information Update: 07 Aug 2012
At a glance
- Drugs Irbesartan (Primary)
- Indications Paroxysmal atrial fibrillation
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 01 Nov 2007 Status changed from in progress to completed.
- 25 Jul 2007 Status changed from recruiting to in progress
- 03 Oct 2006 New trial record.